U.S. Stem Cells Market Size, Share & Trends Analysis Report By Product (Adult Stem Cells, HESCs), By Application (Regenerative Medicine, Drug Discovery and Development), By Therapy, By End-use, And Segment Forecasts, 2024 - 2030­

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Product
                       1.2.2. Application
                       1.2.3. Technology
                       1.2.4. Therapy
                       1.2.5. End-use
                       1.2.6. Estimates and forecasts timeline
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                       1.4.5. Details of primary research
                           1.4.5.1. Data for primary interviews in U.S.
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity flow analysis (Model 1)
                       1.7.2. Approach 1: Commodity flow approach
                   1.8. List of Secondary Sources
                   1.9. List of Primary Sources
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Product Outlook
                       2.2.2. Application Outlook
                       2.2.3. Technology Outlook
                       2.2.4. Therapy Outlook
                       2.2.5. End-use Outlook
                   2.3. Competitive Insights
Chapter 3. U.S. Stem Cells Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market driver analysis
                           3.2.1.1. Ongoing developments in regenerative medicine
                           3.2.1.2. Rising funds for accelerating stem cell research
                           3.2.1.3. Growing demand for stem cell banking
                           3.2.1.4. Increasing prevalence of genetic disorders
                       3.2.2. Market restraint analysis
                           3.2.2.1. Ethical concern related to stem cell research
                           3.2.2.2. Lack of a well-defined regulatory framework in certain applications of stem cell
                   3.3. U.S. Stem Cells Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s Five Forces
                       3.3.2. PESTEL Analysis
Chapter 4. U.S. Stem Cells Market: Product Estimates & Trend Analysis
                   4.1. U.S. Stem Cells Market: Product Dashboard
                   4.2. U.S. Stem Cells Market: Product Movement Analysis
                   4.3. U.S. Stem Cells Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                   4.4. Adult Stem Cells (ASCs)
                       4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.4.2. Hematopoietic
                           4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.4.3. Mesenchymal
                           4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.4.4. Neural
                           4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.4.5. Epithelial/Skin
                           4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.4.6. Others
                           4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   4.5. Human Embryonic Stem Cells (HESCs)
                       4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   4.6. Induced Pluripotent Stem Cells (iPSCs)
                       4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   4.7. Very Small Embryonic Like Stem Cells
                       4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Stem Cells Market: Application Estimates & Trend Analysis
                   5.1. U.S. Stem Cells Market: Application Dashboard
                   5.2. U.S. Stem Cells Market: Application Movement Analysis
                   5.3. U.S. Stem Cells Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                   5.4. Regenerative Medicine
                       5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.2. Neurology
                           5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.3. Orthopedics
                           5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.4. Oncology
                           5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.5. Hematology
                           5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.6. Cardiovascular and Myocardial Infraction
                           5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.7. Injuries
                           5.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.8. Diabetes
                           5.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.9. Liver Disorder
                           5.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.10. Incontinence
                           5.4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.11. Others
                           5.4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   5.5. Drug Discovery and Development
                       5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Stem Cells Market: Technology Estimates & Trend Analysis
                   6.1. U.S. Stem Cells Market: Technology Dashboard
                   6.2. U.S. Stem Cells Market: Technology Movement Analysis
                   6.3. U.S. Stem Cells Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                   6.4. Cell Acquisition
                       6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       6.4.2. Bone Marrow Harvest
                           6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       6.4.3. Umbilical Blood Cord
                           6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       6.4.4. Apheresis
                           6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   6.5. Cell Production
                       6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       6.5.2. Therapeutic Cloning
                           6.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       6.5.3. In-vitro Fertilization
                           6.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       6.5.4. Cell Culture
                           6.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       6.5.5. Isolation
                           6.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   6.6. Cryopreservation
                       6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   6.7. Expansion and Sub-culture
                       6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. U.S. Stem Cells Market: Therapy Estimates & Trend Analysis
                   7.1. U.S. Stem Cells Market: Therapy Dashboard
                   7.2. U.S. Stem Cells Market: Therapy Movement Analysis
                   7.3. U.S. Stem Cells Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                   7.4. Autologous
                       7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   7.5. Allogenic
                       7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. U.S. Stem Cells Market: End-use Estimates & Trend Analysis
                   8.1. U.S. Stem Cells Market: End-use Dashboard
                   8.2. U.S. Stem Cells Market: End-use Movement Analysis
                   8.3. U.S. Stem Cells Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                   8.4. Pharmaceutical & Biotechnology Companies
                       8.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   8.5. Hospitals & Cell Banks
                       8.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   8.6. Academic & Research Institutes
                       8.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
                   9.1. Recent Developments & Impact Analysis, By Key Market Participants
                   9.2. Company/Competition Categorization
                   9.3. Vendor Landscape
                       9.3.1. Key company market share analysis, 2023
                       9.3.2. Thermo Fisher Scientific, Inc.
                           9.3.2.1. Company overview
                           9.3.2.2. Financial performance
                           9.3.2.3. Product benchmarking
                           9.3.2.4. Strategic initiatives
                       9.3.3. STEMCELL Technologies Inc.
                           9.3.3.1. Company overview
                           9.3.3.2. Financial performance
                           9.3.3.3. Product benchmarking
                           9.3.3.4. Strategic initiatives
                       9.3.4. Merck KGaA
                           9.3.4.1. Company overview
                           9.3.4.2. Financial performance
                           9.3.4.3. Product benchmarking
                           9.3.4.4. Strategic initiatives
                       9.3.5. CellGenix GmbH
                           9.3.5.1. Company overview
                           9.3.5.2. Financial performance
                           9.3.5.3. Product benchmarking
                           9.3.5.4. Strategic initiatives
                       9.3.6. PromoCell GmbH
                           9.3.6.1. Company overview
                           9.3.6.2. Financial performance
                           9.3.6.3. Product benchmarking
                           9.3.6.4. Strategic initiatives
                       9.3.7. Takara Bio
                           9.3.7.1. Company overview
                           9.3.7.2. Financial performance
                           9.3.7.3. Product benchmarking
                           9.3.7.4. Strategic initiatives
                       9.3.8. Lonza
                           9.3.8.1. Company overview
                           9.3.8.2. Financial performance
                           9.3.8.3. Product benchmarking
                           9.3.8.4. Strategic initiatives
                       9.3.9. Cellartis AB
                           9.3.9.1. Company overview
                           9.3.9.2. Financial performance
                           9.3.9.3. Product benchmarking
                           9.3.9.4. Strategic initiatives
                       9.3.10. ATCC
                           9.3.10.1. Company overview
                           9.3.10.2. Financial performance
                           9.3.10.3. Product benchmarking
                           9.3.10.4. Strategic initiatives
                       9.3.11. AcceGen
                           9.3.11.1. Company overview
                           9.3.11.2. Financial performance
                           9.3.11.3. Product benchmarking
                           9.3.11.4. Strategic initiatives
                       9.3.12. Bio-Techne
                           9.3.12.1. Company overview
                           9.3.12.2. Financial performance
                           9.3.12.3. Product benchmarking
                           9.3.12.4. Strategic initiatives

List of Tables

Table 1. List of abbreviations
Table 2. U.S. Stem Cells Market, by Product, 2018 - 2030 (USD Million)
Table 3. U.S. Stem Cells Market, by Application, 2018 - 2030 (USD Million)
Table 4. U.S. Stem Cells Market, by Technology, 2018 - 2030 (USD Million)
Table 5. U.S. Stem Cells Market, by Therapy, 2018 - 2030 (USD Million)
Table 6. U.S. Stem Cells Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 U.S. stem cells market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 End-use and end-use segment snapshot
Fig. 10 Sales channel and age segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Market dynamics
Fig. 13 Porter’s Five Forces analysis
Fig. 14 PESTLE analysis
Fig. 15 U.S. stem cells market: Product outlook and key takeaways
Fig. 16 U.S. stem cells market: Product movement analysis
Fig. 17 Adult stem cells (ASCs) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Hematopoietic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Mesenchymal market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Neural market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Epithelial/skin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Human embryonic stem cells (HESCs) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Induced pluripotent stem cells (iPSCs) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Very small embryonic like stem cells market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 U.S. stem cells market: Application outlook and key takeaways
Fig. 27 U.S. stem cells market: Application movement analysis
Fig. 28 Regenerative medicine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Neurology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Orthopedics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Cardiovascular and myocardial infraction market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Injuries market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Liver disorder market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Incontinence market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Drug Discovery and Development
Fig. 40 U.S. stem cells market: Technology outlook and key takeaways
Fig. 41 U.S. stem cells market: Technology movement analysis
Fig. 42 Cell acquisition market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Bone marrow harvest market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Umbilical blood cord market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Apheresis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Cell production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Therapeutic cloning market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 In-vitro fertilization market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Cell culture market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Isolation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Cryopreservation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Expansion and sub-culture market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 U.S. stem cells market: Therapy outlook and key takeaways
Fig. 54 U.S. stem cells market: Therapy movement analysis
Fig. 55 Autologous market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Allogenic harvest market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 U.S. stem cells market: End-use outlook and key takeaways
Fig. 58 U.S. stem cells market: End-use movement analysis
Fig. 59 Pharmaceutical & biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Hospitals & cell banks market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Academic & research institutes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Company market share analysis, 2023
Fig. 63 Strategic framework